Skip to main content

Guardant Health, Inc.

corporate_fare Company Profile

Guardant Health, Inc.

GH·NASDAQ·Industrial Applications And Services·CIK 0001576280

Guardant Health, Inc. is a precision oncology company focused on cancer care. The company transforms patient care by providing insights into disease drivers through advanced blood and tissue tests, real-world data, and AI analytics. Their tests aim to improve outcomes across all stages of care, including early cancer screening, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For advanced-stage cancer patients, Guardant Health offers the Guardant360 Liquid test (formerly Guardant360 LDT) and the Guardant360 CDx test. The Guardant360 CDx test is the first comprehensive liquid biopsy test approved by the U.S. Food and Drug Administration (FDA) for tumor mutation profiling with solid tumors and as a companion diagnostic for non-small cell lung cancer (NSCLC), colorectal cancer, and breast cancer. They also provide the Guardant360 Tissue test for advanced-stage cancer and the Guardant Reveal test for detecting residual and recurring disease in early-stage colorectal, breast, and lung cancer patients. The Guardant Reveal test has been expanded to include late-stage therapy response monitoring for patients with solid tumors. The product portfolio is powered by the Smart Platform, which uses methylation technology with genomic, epigenomic, and RNA-based data, proprietary chemistry, advanced algorithms, and the InfinityAI learning engine. Guardant Health collaborates with biopharmaceutical companies in clinical studies, offering the aforementioned tests, as well as the GuardantINFINITY blood test (also powered by the Smart Platform) and the GuardantOMNI blood test for advanced-stage cancer. The GuardantINFORM platform, developed using data from their tests and AI-enabled analytical tools, assists biopharmaceutical companies in accelerating precision oncology drug development by providing insights into tumor evolution and treatment resistance across various biomarker-driven cancers.

Guardant Health, Inc. (NASDAQ:GH) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 24 items for GH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for GH spans 8-K, 10-Q, DEF 14A.

Recent high-impact activity:

  • Guardant Closes Upsized $550M 0% Convertible Notes Due 2032, Refinances 2027 Notes
  • $500M 0% Convertible Notes Priced at 35% Premium; Proceeds to Retire 2027 Notes
  • $500M Convertible Notes Offering Announced, With 2027 Note Repurchase
  • Guardant Q3 Revenue Jumps 36% to $361M; Convertible Notes Turn Convertible
  • Q3 Revenue Jumps 36% to $361M, 2026 Guidance Raised on Shield Momentum

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$982.02M
Net Income
-$416.28M
Diluted EPS
-$3.32
Op. Cash Flow
-$184.76M
Free Cash Flow
-$233.07M
Gross Profit
$633.01M
Operating Income
-$437.25M
Cash & Equivalents
$378.2M
Total Debt
$1.5B
Debt / Equity
-15.14×
Net Margin
-42.4%
Shares Outstanding
130.64M sh
Source: 10-K · filed 2026-02-19 · accession 0001576280-26-000013

Short Interest & Short Volume

5.38 days to cover

FINRA reported short interest of 9,433,137 shares in GH as of the October 30, 2026 settlement, a 19.2% decrease from the prior period — about 5.4 days to cover at its recent average daily volume. On November 20, 2026, 41.1% of GH volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)9,433,137 shares as of October 30, 2026
Change vs prior period▼ 19.2%
Days to cover5.38 at avg daily volume of 1,752,636
Daily short volume (FINRA facilities)41.1% of 1,406,572 shares on November 20, 2026
5-day average short volume45.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for GH, detected from its recent SEC filings · based on capital-structure filings through 2026-11-16.

1 shelf registration

Upsized $550M Convertible Notes Close · Proceeds Refinance 2027 Notes

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with G →
$145.83
52-week range · as of 2026-11-16 $74.55 – $191.05
Market cap
$19.73B
Volume
2.8M (1.3× avg)
3-mo avg 2.1M
Live data · 2026-11-22 12:35 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed GH - Latest Insights

GH
Nov 16, 2026, 4:19 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $142.80
Real-time Price: $145.83 info
Change: +$3.03 (+2%) info
Market Cap: $19.729B info
GH
Nov 12, 2026, 1:09 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $155.00
Real-time Price: $145.83 info
Change: -$9.17 (-6%) info
Market Cap: $19.729B info
GH
Nov 11, 2026, 4:17 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $154.78
Real-time Price: $145.83 info
Change: -$8.95 (-6%) info
Market Cap: $19.729B info
GH
Nov 05, 2026, 5:13 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $130.02
Real-time Price: $145.83 info
Change: +$15.81 (+12%) info
Market Cap: $19.729B info
GH
Nov 05, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $159.34
Real-time Price: $145.83 info
Change: -$13.51 (-8%) info
Market Cap: $19.729B info
GH
Oct 08, 2026, 4:12 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $165.56
Real-time Price: $145.83 info
Change: -$19.73 (-12%) info
Market Cap: $19.729B info
GH
Sep 04, 2026, 3:44 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $156.46
Real-time Price: $145.83 info
Change: -$10.63 (-7%) info
Market Cap: $19.729B info
GH
Aug 24, 2026, 7:20 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $170.05
Real-time Price: $145.83 info
Change: -$24.22 (-14%) info
Market Cap: $19.729B info
GH
Jul 31, 2026, 11:54 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $162.37
Real-time Price: $145.83 info
Change: -$16.54 (-10%) info
Market Cap: $19.729B info
GH
Jul 30, 2026, 4:46 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $167.40
Real-time Price: $145.83 info
Change: -$21.57 (-13%) info
Market Cap: $19.729B info
GH
Jul 30, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $162.00
Real-time Price: $145.83 info
Change: -$16.17 (-10%) info
Market Cap: $19.729B info
GH
Jun 18, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $131.78
Real-time Price: $145.83 info
Change: +$14.05 (+11%) info
Market Cap: $19.729B info
GH
Jun 12, 2026, 11:51 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $131.11
Real-time Price: $145.83 info
Change: +$14.72 (+11%) info
Market Cap: $19.729B info
GH
May 20, 2026, 8:42 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $101.09
Real-time Price: $145.83 info
Change: +$44.74 (+44%) info
Market Cap: $19.729B info
GH
May 07, 2026, 5:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $94.19
Real-time Price: $145.83 info
Change: +$51.64 (+55%) info
Market Cap: $19.729B info
GH
May 07, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $94.05
Real-time Price: $145.83 info
Change: +$51.78 (+55%) info
Market Cap: $19.729B info
GH
May 07, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $95.08
Real-time Price: $145.83 info
Change: +$50.75 (+53%) info
Market Cap: $19.729B info
GH
May 04, 2026, 8:14 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $87.10
Real-time Price: $145.83 info
Change: +$58.73 (+67%) info
Market Cap: $19.729B info
GH
Apr 28, 2026, 4:46 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $83.50
Real-time Price: $145.83 info
Change: +$62.33 (+75%) info
Market Cap: $19.729B info
GH
Apr 27, 2026, 5:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $88.50
Real-time Price: $145.83 info
Change: +$57.33 (+65%) info
Market Cap: $19.729B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets